Blog / Archives
RaynoLifeScience Portfolio: Earnings Update-ABAX,GPRO
Abaxis (ABAX) beat estimates with reported Q3 Revenues of $35.3M/$0.17 up 17% over last year's comparable quarter. Cash position is $100.6M up from $87.6M last year's Q3. March '11 Fiscal Year...
Trading Update:Exact Sciences (EXAS) Reports Positive Data for Colorectal Cancer Test
EXAS -Big Sell-Off on the News Exact Sciences (EXAS) was down 20% today after presenting its first validation data on the performance of its experimental, non-invasive colorectal cancer test. As of...
Great Day for Biotech Tools:Earnings Up ILMN,LIFE and PacBio (PACB) IPO
Timing is everything and Pacific Biosciences(PACB) took advantage of a good year for biotech stocks, better earnings for tools and Dx companies and a rebounding IPO market. Pacific Biosciences...
GE Buys Oncology Diagnostic Co. Clarient (CLRT)-Update- Dx Movers
GE announced the purchase of Clarient (CLRT) for $5/share or $580M, a 34% premium over Clarient's previous closing price. Revenues forecasted for 2011 and 2012 are at $114M and $136M respectively,...
Rayno Life Science Portfolio Big Movers: Gilead (GILD),Supergen (SUPG)
Risk is on today due to a weak dollar and that is usually good for Life Science stocks.MidCap biotechs are mainly green despite bad news from Amylin (AMLN) $11.35 down 44%, and partner Alkermes...
Rayno Life Science Portfolio Notes- Q3 Earnings in Two weeks
The Rayno Life Science Portfolio is up 20% and later this month we will see important earnings reports from tools and diagnostics companies. Life Science stocks are outperforming the NASDAQ and...
IMMUCOR(BLUD) Cuts Guidance,Economy and Blood Demand Cited-Update 1
Stock is down over 18% at 3p near $16.5 on 7M shares A "Pure Play "Immunohematology Diagnostic Company Immucor announced Fiscal Q1 2011 results yesterday with a revenue shortfall of (9%) on...
Rayno Life Science Portfolio: Update Tools and Dx
2010 Original Price % Ret. P Price % Recomm 3/29/10 Q2 12/1/10 Ret. Abaxis ABAX 2/2/09 15 79 21.2 27.86 85 CardioV.Sys. CSII 11/5/10 7.15 8.65 21 Celera CRA 3/28/10 7 6.49 5.66 -19 GenProbe GPRO...
2010 Rayno Life Science Portfolio: Update Biopharma
2010 Price Original P Price % Ret 7/2/10 Recomm 12/1/10 Alexion ALXN 50.45 2/2/09 35 76.24 117 Ardea Biosci RDEA 19.5 2/2/09 12 22.26 85 Amgen AMGN 51.7 2/2/09 55 53.52 -5 Biogen BIIB 49.42 2/2/09...
Rayno Life Science Portfolio Update: Biotechs beat the Market
As of the end of Q3, 2010 has been a very good year for biotechnology stocks beating both the S&P (up 2.9% YTD) and the NASDAQ (up 4.9% YTD). However the QQQQ was up 7.75% YTD. The NYSE Arca...
